Jaguar Health Inc. Common Stock (JAGX)
Stock · NASDAQ · Health Care
$3.53as of 10/16/2026
Price chart
Active signals
JAGX Signal Track Record
How signals performed across all stocks →What JAGX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 23 | -22.7% | 13% | September 4, 2026 |
| Bollinger Band Breakout | 16 | -27.0% | 6% | September 16, 2026 |
| Volume Spike | 8 | -50.7% | 0% | September 22, 2026 |
| Any 20-session window (baseline) | -18.0% | 22% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About JAGX
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 47
- Website
- jaguar.health/
Fundamentals
- 1-day range
- $4.1$5.99
- Market cap
- $4.61M
- P/E (trailing)
- —
- P/E (forward)
- -0.83
- EPS (trailing)
- $-370.63
- Dividend yield
- —
- Beta
- -0.21
- Avg. volume
- 1.21M
- Dividend pay date
- June 7, 2019
How Jaguar Health Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Apr 7, 2026 · via SEC EDGAR / Finnhub
Jaguar Health Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- JAGXJaguar Health Inc. Common Stock$3.53▼ 23.20%Market cap $4.61MP/E —$2.35$1,268
- RNAZTransCode Therapeutics Inc. Common Stock$1.7▼ 5.56%Market cap $4.52MP/E —$1.52$15.94
- DRMADermata Therapeutics Inc. Common Stock$0.86▼ 5.49%Market cap $4.46MP/E —$0.6032$4.66
- PPCBPropanc Biopharma Inc. Common Stock$0.342▲ 0.15%Market cap $4.76MP/E —$0.365$47.5
- REVBRevelation Biosciences Inc. Common Stock$0.485▼ 36.35%Market cap $4.38MP/E 0.04$0.71$5.8
- ELABPMGC Holdings Inc. Common Stock$2.77▼ 8.88%Market cap $4.34MP/E —$2.59$2,671
- JUNSJupiter Neurosciences Inc. Common Stock$2.9▼ 7.48%Market cap $4.24MP/E —$2.25$135.75
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| JAGX Jaguar Health Inc. Common Stock | $4.61M | — | $3.53 | ▼ 23.20% | $2.35$1,268 |
| RNAZ TransCode Therapeutics Inc. Common Stock | $4.52M | — | $1.7 | ▼ 5.56% | $1.52$15.94 |
| DRMA Dermata Therapeutics Inc. Common Stock | $4.46M | — | $0.86 | ▼ 5.49% | $0.6032$4.66 |
| PPCB Propanc Biopharma Inc. Common Stock | $4.76M | — | $0.342 | ▲ 0.15% | $0.365$47.5 |
| REVB Revelation Biosciences Inc. Common Stock | $4.38M | 0.04 | $0.485 | ▼ 36.35% | $0.71$5.8 |
| ELAB PMGC Holdings Inc. Common Stock | $4.34M | — | $2.77 | ▼ 8.88% | $2.59$2,671 |
| JUNS Jupiter Neurosciences Inc. Common Stock | $4.24M | — | $2.9 | ▼ 7.48% | $2.25$135.75 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split FloatYahoo · 9/25/2026
- Gapping stocks in Friday's sessionChartMill · 9/25/2026
- Jaguar Health Stock Surges Friday: What's Happening?Benzinga · 9/25/2026
- Jaguar Health Announces Issuance Of 182,091 Shares To Streeterville Capital For $1.67832M Reduction In 2021 Note Balance; 2025 Streeterville Note Fully Paid And Cancelled Following Exchange For 547,898 SharesBenzinga · 9/25/2026
- Unusual volume stocks in Thursday's sessionChartMill · 9/24/2026
- Jaguar Health Stock Slides Thursday: What's Happening?Benzinga · 9/24/2026
- The market is filled with gapping stocks in Thursday's session.ChartMill · 9/24/2026
- Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%Yahoo · 9/24/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
JAGX Announces Stock Dividend, Crofelemer Study Presentations
Jaguar Health announced a special stock dividend, giving shareholders additional shares. The company also has two Crofelemer studies accepted for presentation at the American College of Gastroenterology meetings, providing early data on the drug’s use in short bowel syndrome. These events highlight ongoing progress in Jaguar’s product pipeline and shareholder value.
JAGX Announces Stock Dividend, Crofelemer Study Presentations. Jaguar Health announced a special stock dividend, giving shareholders additional shares. The company also has two Crofelemer studies accepted for presentation at the American College of Gastroenterology meetings, providing early data on the drug’s use in short bowel syndrome. These events highlight ongoing progress in Jaguar’s product pipeline and shareholder value.